• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受磷蛋白基因的靶向消融与心肌收缩力显著增强及β-激动剂刺激丧失有关。

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

作者信息

Luo W, Grupp I L, Harrer J, Ponniah S, Grupp G, Duffy J J, Doetschman T, Kranias E G

机构信息

Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, OH 45267-0575.

出版信息

Circ Res. 1994 Sep;75(3):401-9. doi: 10.1161/01.res.75.3.401.

DOI:10.1161/01.res.75.3.401
PMID:8062415
Abstract

Phospholamban is the regulator of the Ca(2+)-ATPase in cardiac sarcoplasmic reticulum (SR), and it has been suggested to be an important determinant in the inotropic responses of the heart to beta-adrenergic stimulation. To determine the role of phospholamban in vivo, the gene coding for this protein was targeted in murine embryonic stem cells, and mice deficient in phospholamban were generated. The phospholamban-deficient mice showed no gross developmental abnormalities but exhibited enhanced myocardial performance without changes in heart rate. The time to peak pressure and the time to half-relaxation were significantly shorter in phospholamban-deficient mice compared with their wild-type homozygous littermates as assessed in work-performing mouse heart preparations under identical venous returns, afterloads, and heart rates. The first derivatives of intraventricular pressure (+/- dP/dt) were also significantly elevated, and this was associated with an increase in the affinity of the SR Ca(2+)-ATPase for Ca2+ in the phospholamban-deficient hearts. Baseline levels of these parameters in the phospholamban-deficient hearts were equal to those observed in hearts of wild-type littermates maximally stimulated with the beta-agonist isoproterenol. These findings indicate that phospholamban acts as a critical repressor of basal myocardial contractility and may be the key phosphoprotein in mediating the heart's contractile responses to beta-adrenergic agonists.

摘要

受磷蛋白是心肌肌浆网(SR)中Ca(2+)-ATP酶的调节因子,有人认为它是心脏对β-肾上腺素能刺激产生变力反应的一个重要决定因素。为了确定受磷蛋白在体内的作用,编码该蛋白的基因在小鼠胚胎干细胞中被靶向,从而培育出缺乏受磷蛋白的小鼠。缺乏受磷蛋白的小鼠没有明显的发育异常,但心肌功能增强,心率没有变化。在相同静脉回流、后负荷和心率条件下,对工作状态的小鼠心脏标本进行评估,结果显示,与野生型纯合子同窝小鼠相比,缺乏受磷蛋白的小鼠达到峰值压力的时间和半舒张时间明显缩短。室内压的一阶导数(+/- dP/dt)也显著升高,这与缺乏受磷蛋白的心脏中肌浆网Ca(2+)-ATP酶对Ca2+的亲和力增加有关。缺乏受磷蛋白的心脏中这些参数的基线水平与用β-激动剂异丙肾上腺素最大程度刺激的野生型同窝小鼠心脏中观察到的水平相当。这些发现表明,受磷蛋白是基础心肌收缩力的关键抑制因子,可能是介导心脏对β-肾上腺素能激动剂收缩反应的关键磷蛋白。

相似文献

1
Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.受磷蛋白基因的靶向消融与心肌收缩力显著增强及β-激动剂刺激丧失有关。
Circ Res. 1994 Sep;75(3):401-9. doi: 10.1161/01.res.75.3.401.
2
Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.肌浆网磷酸受纳蛋白在心脏中的特异性过表达改变了转基因小鼠的钙动力学及由此产生的心肌细胞力学特性。
J Clin Invest. 1996 Jan 15;97(2):533-9. doi: 10.1172/JCI118446.
3
Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.将受磷蛋白基因靶向过表达于小鼠心房会降低钙离子转运和收缩性。
J Mol Cell Cardiol. 1998 Oct;30(10):1991-2002. doi: 10.1006/jmcc.1998.0760.
4
The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.异丙肾上腺素对甲状腺状况改变的磷酸受磷蛋白缺陷型小鼠心脏的影响。
J Mol Cell Cardiol. 1999 Sep;31(9):1725-37. doi: 10.1006/jmcc.1999.1010.
5
Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.发育中小鼠心脏中肌浆网Ca(2+) -ATP酶和受磷蛋白表达的协同调节
Am J Physiol. 1997 Jan;272(1 Pt 2):H57-66. doi: 10.1152/ajpheart.1997.272.1.H57.
6
Monomeric phospholamban overexpression in transgenic mouse hearts.转基因小鼠心脏中单体磷酸受纳蛋白的过表达。
Circ Res. 1997 Oct;81(4):485-92. doi: 10.1161/01.res.81.4.485.
7
The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility.受磷蛋白与肌浆网钙ATP酶2的相对比率:心肌收缩力的关键决定因素。
Basic Res Cardiol. 1997;92 Suppl 1:17-24. doi: 10.1007/BF00794064.
8
Phospholamban gene dosage effects in the mammalian heart.磷酸受磷蛋白基因剂量对哺乳动物心脏的影响。
Circ Res. 1996 May;78(5):839-47. doi: 10.1161/01.res.78.5.839.
9
Phospholamban ablation and compensatory responses in the mammalian heart.哺乳动物心脏中受磷蛋白缺失及代偿反应
Ann N Y Acad Sci. 1998 Sep 16;853:49-62. doi: 10.1111/j.1749-6632.1998.tb08256.x.
10
Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.慢性肌浆网钙ATP酶抑制会导致细胞钙转运的适应性变化。
Circ Res. 2003 Apr 18;92(7):769-76. doi: 10.1161/01.RES.0000066661.49920.59. Epub 2003 Mar 13.

引用本文的文献

1
Aging diastole - root cause for atrial fibrillation and heart failure with preserved ejection fraction.舒张期老化——心房颤动和射血分数保留的心力衰竭的根本原因。
J Cardiovasc Aging. 2024 Dec;4(4). doi: 10.20517/jca.2024.22. Epub 2024 Dec 23.
2
Emerging roles for microproteins as critical regulators of endoplasmic reticulum function and cellular homeostasis.微蛋白作为内质网功能和细胞稳态的关键调节因子的新作用。
Semin Cell Dev Biol. 2025 Jun;170:103608. doi: 10.1016/j.semcdb.2025.103608. Epub 2025 Apr 17.
3
Another-regulin regulates cardiomyocyte calcium handling via integration of neuroendocrine signaling with SERCA2a activity.
另一种内啡肽通过将神经内分泌信号与 SERCA2a 活性整合来调节心肌细胞钙处理。
J Mol Cell Cardiol. 2024 Dec;197:45-58. doi: 10.1016/j.yjmcc.2024.10.008. Epub 2024 Oct 20.
4
A novel role for phospholamban in the thalamic reticular nucleus.磷蛋白在丘脑网状核中的新作用。
Sci Rep. 2024 Mar 16;14(1):6376. doi: 10.1038/s41598-024-56447-x.
5
Myofilament-based physiological regulatory compensation preserves diastolic function in failing hearts with severe Ca2+ handling deficits.基于肌丝的生理调节代偿可在严重钙处理缺陷的衰竭心脏中维持舒张功能。
JCI Insight. 2024 Feb 8;9(6):e163334. doi: 10.1172/jci.insight.163334.
6
Polyarginine Cell-Penetrating Peptides Bind and Inhibit SERCA2.聚精氨酸细胞穿透肽结合并抑制肌浆网Ca2+-ATP酶2
Cells. 2023 Sep 26;12(19):2358. doi: 10.3390/cells12192358.
7
Biochemistry and Protein Interactions of the CYREN Microprotein.CYREN 微蛋白的生化与蛋白质相互作用。
Biochemistry. 2023 Nov 7;62(21):3050-3060. doi: 10.1021/acs.biochem.3c00397. Epub 2023 Oct 9.
8
1821-2021: Contributions of physicians and researchers of Greek descent in the advancement of clinical and experimental cardiology and cardiac surgery.1821年至2021年:希腊裔医生和研究人员在临床与实验心脏病学及心脏外科发展中的贡献。
Front Cardiovasc Med. 2023 Aug 4;10:1231762. doi: 10.3389/fcvm.2023.1231762. eCollection 2023.
9
Microproteins: Overlooked regulators of physiology and disease.微小蛋白:被忽视的生理与疾病调节因子。
iScience. 2023 Apr 29;26(6):106781. doi: 10.1016/j.isci.2023.106781. eCollection 2023 Jun 16.
10
Phospholamban R14del disease: The past, the present and the future.受磷蛋白R14缺失影响的疾病:过去、现在与未来
Front Cardiovasc Med. 2023 Apr 18;10:1162205. doi: 10.3389/fcvm.2023.1162205. eCollection 2023.